X0306 4 2020-02-20 0000313616 DANAHER CORP /DE/ DHR 0001608367 King William 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W WASHINGTON DC 20037 0 1 0 0 SVP, Strategic Development Common Stock 2020-02-20 4 A 0 3135 160.26 A 22427 D Common Stock 2020-02-20 4 S 0 2462 160.118 D 19965.00 D Common Stock 2020-02-20 4 S 0 100 160.770 D 19865 D Common Stock 2020-02-20 4 M 0 8808 40.45 A 28673 D Common Stock 2020-02-20 4 S 0 6904 160.061 D 21769 D Common Stock 2020-02-20 4 S 0 1904 161.138 D 19865 D Common Stock 2020-02-20 4 M 0 15000 46.13 A 34865 D Common Stock 2020-02-20 4 S 0 13100 160.098 D 21765 D Common Stock 2020-02-20 4 S 0 1900 160.922 D 19865 D Common Stock 12.51 I by 401k Employee Stock Option (Right to Buy) 40.45 2020-02-20 4 M 0 8808 0 D 2022-02-23 Common Stock 8808 0 D Employee Stock Option (Right to Buy) 46.13 2020-02-20 4 M 0 15000 0 D 2023-02-21 Common Stock 15000 8232 D On February 24, 2017, the Compensation Committee of the Company's Board of Directors awarded the reporting person performance stock units under the Danaher Corporation 2007 Omnibus Incentive Plan. This Form 4 is being filed in connection with the determination by the Compensation Committee that the performance criteria of the award have been achieved. The award remains subject to a holding period that continues through December 31, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.75 to $160.68, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.69 to $160.68, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.75 to $161.49, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.68 to $160.62, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.68 to $161.04, inclusive. The options granted became exercisable on the third, fourth and fifth anniversaries of the grant date, which was February 23, 2012. The options granted became exercisable on the third, fourth and fifth anniversaries of the grant date, which was February 21, 2013. James F. O'Reilly, attorney-in-fact for William King 2020-02-21